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Modulation of type IV collagenase and plasminogen activator in a
hamster fibrosarcoma by basement membrane components and lung
fibroblasts
D.M. Teale*, I.A. Khidair, C.W. Potter & R.C. Rees
Department of Virology, University of Sheffield Medical School, Beech Hill Road, Sheffield SJO 2RX, UK.
Summary The effect of basement membrane components (laminin, fibronectin and type IV collagen) and
lung fibroblasts on type IV collagenase and plasminogen activator activity was investigated in a primary
HSV-2-induced hamster fibrosarcoma, and its in vivo derived sublines and in vitro derived clones of varying
metastatic potential.
Fibronectin and type IV collagen were ineffective at influencing the expression of either type IV collagenase
or plasminogen activator activity. Laminn, however, at concentrations of 1-10 ugml-l added to the serum-
free culture supernatants, increased the release of type IV collagenase by up to 100% for the parental cell line.
Three highly metastatic sublines (two from in vivo origin and one from in vitro cloning) showed increases of
up to 300%. Non-metastic sublines (two from in vivo origin and one from in vitro cloning), however, showed
no increase in type IV collagenase activity. Plasminogen activator release from either the parental line cell or
its metastatic sublines and clones, was unaffected by the addition of laminin.
Addition of tumour cells to lung fibroblast monolayers resulted in an increased expression of PA activity in
the supernatant, whilst type IV collagenase activity was reduced.
Metastasizing tumour cells traverse epithelial and endothelial
basement membranes (BM) whilst extravasating from the
circulation and invading the target organ (Thorgeirsson et
al., 1984). Type IV collagenase, a metalloproteinase, has
been demonstrated to be the specific enzyme capable of
degrading type IV collagen, the structural back bone of the
BM (Timpl et al., 1981; Liotta et al., 1980). Other
components of the BM are non-collagenous glycoproteins
such as laminin and fibronectin (Timpl et al., 1979; Carlin et
al., 1981; Kanwar et al., 1979).
Several tumours have previously been demonstrated to
secrete increased quantities of type IV collagenase compared
with their non-malignant cell type (Salo et al., 1982). The
metastatic potential of tumour cells has also been shown to
correlate with their in vitro ability to degrade type IV
collagen (Liotta et al., 1980, 1981; Nakajima et al., 1987)
and more recently the increased expression of type IV
collagenase activity has been associated with the in-
creased metastatic activity of murine tumour cell hybrids
(Turpeeniemi-Hujanen et al., 1985).
In a recent report from this laboratory, we were unable to
correlate type IV-collagen-degrading metalloproteinase
activity of a spontaneously metastatic HSV-2 induced
hamster fibrosarcoma with metastatic potential, Thus,
sublines established from secondary lung nodules occurring
following resection of the primary tumour, and in vitro
derived clones of the parental tumour, of established
metastatic potential, were heterogenous with respect to type
IV collagenase activity (Teale et al., 1987). Attachment to
the basement membrane is a prerequisite to dissolution of
the extracellular matrix (Liotta et al., 1977, 1986) and
experiments performed in vitro have demonstrated tumour
cell binding to the basement membrane using laminin as the
attachment factor (Terranova et al., 1982). We have,
therefore, assessed the influence of BM components, and
lung fibroblasts, on the secretion of type IV collagenase in
sublines and clone of defined metastatic ability in the
hamster tumour model (Walker et al., 1982; Teale & Rees,
1987; Teale et al., 1983,1984; Khidair et al., 1986). The
secretion of plasminogen activator (PA), a serine protease
capable of degrading serum plasminogen converting it to
plasmin, which in turn is capable of degrading fibrin and
laminin (Carlson et al., 1984; Liotta et al., 1981), was also
investigated in this system.
Materials and methods
Animals
Male, Syrian golden hamsters, aged between 6 and 10 weeks
and weighing 60-90 grams were used in all experiments. The
animals were obtained from a closed randomly bred colony
at the University of Sheffield and have previously been shown
to be syngeneic by skin grafting experiments (Potter &
Jennings, unpublished) and mixed lymphocyte reactions in
vitro (Teale, unpublished).
Tumours
The HSV-2-333-2-26 cell line (parent) used in the current
study was originally obtained by in vitro transformation of
hamster embryo fibroblasts with inactivated HSV-2; this cell
line was provided by Dr F. Rapp (Department of
Microbiology, Pennsylvania State University, Hershey,
USA).
The four sublines met B, met C, met F and met G were
derived from lung nodules in hamsters whose primary parent
load had previously been resected; following in vivo passage,
in vitro cultures were established and used within 10
passages. Clones S4A and S9E were obtained following
double cloning of the parental cell line by the limiting
dilution method (Teale & Rees, 1987). Some of the
characteristics of the in vivo and in vitro derived cell lines
have been reported previously (Walker et al., 1982; Teale &
Rees, 1987; Teale et al., 1983,1984; Khidair et al., 1986) and
are summarised in Table I.
Lung fibroblasts
Lungs from one-week old baby hamsters were minced with
forceps and scalpel, digested with 0.25% trypsin (w/v) con-
taining DNAase (0.02% w/v) and the cell suspensions seeded
into 25cm3 plastic tissue culture flasks in Complete Modified
Eagles Medium (CMEM) supplemented with 10% foetal calf
serum (FCS), and 50jgml- 1 penicillin, 50kgml -
streptomycin and 50gml-1 gentamycin.
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Table I Type IV collagenase and plasminogen activator activity for the parent cell line and
its in vivo sublines and in vitro clones.
% PA
Cell Metastatic Type IV collagenase activity 10-5
line Origin ability (cpm 10-6 cells) cells
Parent primary tumour Low 80+7.2 20+1.1
(HSV-2 transformed)
fibroblasts
Met B Lung nodule High 40+4.3 20+0.9
Met C following Low/none 110+14.2 29+0.6
Met F parent tumour High 50+13.9 36+0.9
Met GJ resection Low/none 280+38.3 30+1.3
S4A Limiting High 48+9.4 28+0.7
S9E dilution clones None 70+6.3 32+0.9
The trend in results is representative of several repeat experiments. The parent tumour
was originally obtained by transformation of hamster embryo fibroblasts with inactivated
HSV-2. Lung nodules were obtained following primary parent tumour resection and
implanted s.c. and passaged in vivo prior to establishment of in vitro cell lines. S4A and S9E
were obtained following double limiting dilution cloning of the parent cell line. Metastatic
ability was assessed following s.c. inoculation of 104 tumour cells and the resulting tumour
mass excised at 10-15mm mean diameter. Animals were observed for signs of illness or
respiratory distress and were sacrificed when moribund. Metastases occurred in the lungs,
pleural cavity, kidneys and regional lymph nodes (Teale et al., 1984; Teale and Rees, 1987).
Cell cultures
All cell lines were maintained in CMEM, and incubated at
37°C in a humidified atmosphere containing 5% CO2.
Collection of media and preparation for enzyme assay
Four T175cm2 sub-confluent flasks of each cell line were
washed X3 with Hanks balanced salt solution (HBSS) and
incubated in 25ml of serum-free CMEM for 24hrs. The
media was collected, centrifuged to remove free cells and the
supernatant concentrated 100-fold with ammonium sulphate
precipitation (0-60%) and dialysed against 0.2 MNaCl,
0.05 M Tris HCI, 5mM CaCI2 pH7.6 at 4°C. This pre-
paration (1.Oml) was stored at -20°C prior to assay for
type IV collagenase.
Preparation of substrates
Type IV collagen was biosynthetically labelled with 14C-
proline (5mCimmol-1) from organ cultures of ESH sarcoma
as described previously (Tryggvason et al., 1980) and
purified according to Liotta et al. (1981). Substrate pre-
paration was checked for purity by SDS-PAGE and stored
frozen in 0.5 M acetic acid until use.
Type IV collagenase assay
BM collagenase activity was assayed as described previously
(Liotta et al., 1981; Turpeeniemi-Hujanen et al., 1985; Teale
et al., 1987) by using soluble 3H-proline-labelled type IV
procollagen. The substrate, 6000cpm, was added in 50yl of
reaction buffer (specific activity of 240cpmpg-1 protein).
The enzyme sample was activated with 10 ugml-P of trypsin
for 10min at 37°C and assayed in the presence of 50pgml-1
SBTI for 1Oh at 37°C. These conditions have previously been
demonstrated to activate latent hamster fibrosarcoma type
IV collagenase (Teale et al., 1987). The reaction was
terminated by inactivating the samples at 4°C for 90min in
the presence of 20p1 bovine serum albumin (5mgml-1),
0.6% trichloroacetic acid (TCA) and 0.03% tannic acid. The
undigested TCA precipitated substrate was centrifuged and
the radioactivity of the supernatant counted in a f-scintil-
lation counter. The amount of degraded type IV collagen
was then calculated from the total amount of radio-labelled
substrate (8000cpm). Bacterial collagenase was used as a
positive control to achieve maximum degradation levels
whilst samples without enzyme or with EDTA or STB1
alone were included as negative controls.
Experiments to characterise the enzyme activity by SDS
polyacrylamide gel electrophoresis indicated the Type IV
pro-collagen substrate to yield two sets of cleavage products
(results not shown) consistent with cleavage products re-
ported in other systems (Liotta et al., 1981; Teale et al.,
1987).
Cell counts, using a haemocytometer, were performed on
trypsinised cell monolayers plus the centrifuged pellet of the
collection media.
Assay for plasminogen activator
Preparation Of 125I-labelledfibrin plates
Bovine fibrinogen (Sigma F8630) was purified from
contaminating traces of plasminogen by the precipitation
method and subsequently radiolabelled with 1251I. Two
hundred ml of 1OOugml-P purified fibrinogen solution was
mixed with the content of one vial of 125I human fibrinogen
(11OyCi) that had been resuspended in phosphate-buffered
saline (PBS). Two hundred pl of the radiolabelled fibrinogen
solution was added to each well of a 24-well tissue culture
plate (Falcon 3047), dried at 37°C and exposed to ultraviolet
(UV) light for 30min to minimize the risk of contamination.
Plates were stored at -20°C until required for use.
Preparation ofplasminogen
Plasminogen was extracted from rabbit serum by affinity
chromatography with lysine sepharose 4B as previously
described. Plasminogen was titrated by the addition of
increasing quantities ofplasminogen to a constant amount of
supernatant from the cell culture. The amount of
plasminogen that gave maximum release of radioactivity was
determined and used in all subsequent experiments (100p1).
Extracellular PA activity
In vitro cell cultures were prepared from in vivo tissue
(normal or tumour) as previously described. The cells were
cultured in 60-mm plastic petri dishes (Sterilin, 303) in 5ml
of Hams FIO media (10% NBCS) at a concentration of
3 x 104 cells ml-1 and incubated for 24h at 37°C (5%
CO /95% air). The cells were washed twice with PBS to
remove traces of serum and incubated with 5ml Hams FIO
media (serum-free) for an additional 5h. The supernatants
were centrifuged at 200rpm for 5min, collected, and stored
at -20°C. The remaining cells were treated with trypsin and
counted so that activities could be expressed with respect to
the cell number. The fibrinolytic assay was performed by
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plasminogen for 1 h, followed by a transfer to 125I-labelled
fibrin plates. The fibrin plates had previously been incubated
with Hams FIO media for 2h to allow the conversion of
fibrinogen to fibrin through the action of thrombin present
in the NBCS of the medium. Any traces of serum were
removed from the plates by washing two times with PBS.
The plates were then incubated with the supernatants at
37-C (5% C02/95% air) for 8h. The supernatants were then
transferred to plastic vials and counted for one minute in an
alpha-spectrophotometer. The residual fibrin present in the
plates was digested with 0.1% trypsin for 24h. Thus, the
degradation of fibrin by the supernatants in the first 8 h was
expressed as a percentage of the total fibrin in each well
using the following formula:
%PA= [(cpm 1251 fibrin released by experimental
sample)-(cpm 1251 fibrin released by media unexposed to
cells)]/[(cpm 1251 fibrin released after total lysis by
trypsin) x 100]
The supernatants were assayed in triplicate. Media that had
not been incubated with cells were incubated with
plasminogen and used as control, to exclude any
spontaneous release of radioactivity from the labelled plates.
PA activity of the hamster fibrosarcoma cell lines has
previously been shown to be of a secreted form and not cell
bound (Khidair et al., 1986).
Reagents
Laminin and fibronectin were obtained from Collaborative
Research, Spring Street, Lexington, Mass. Type IV collagen
was purified from the ESH sarcoma as described by Timpl et
al., 1979, and the purity was demonstrated by gel electro-
phoresis.
Addition of laminin, fibronectin and type IV collagen to
culture cells
Laminin and fibronectin were reconstituted to the required
concentration in sterile distilled water. Tissue culture flasks
(175cm2) and 50mm plastic petri dishes were coated by
adding sufficient volume to cover the substrate surface,
incubated at room temperature for 45min, drained and
allowed to dry. Type IV collagen was obtained in phosphate
buffered saline and coating of the substrate was performed
as above.
Laminin, fibronectin and type IV collagen previously
diluted in serum-free medium were also added directly to
serum-free collection supernatants.
Results
Effect of laminin, fibronectin and type IV collagen on the
secretion of type IV collagenase by the parent tumour and
its subline met B
The parental cell line and met B cells were grown to
subconfluency prior to adding laminin (1-8pgml-1),
fibronectin (1-20pgml-1) or type IV collagen (1-20pgml 1)
to the serum-free culture supernatants (see Figure 1).
Type IV collagenase activity was increased up to 100% for
the parent cell line in the presence of laminin. Fibronectin
and type IV collagen did not modify the type IV collagenase
activity at any of the concentrations used. Precoating tissue
culture flasks with fibronectin or type IV collagen was also
ineffective at altering the expression of type IV collagenase
(results not shown).
Similar results were obtained for met B cells. Thus,
increases in type IV collagenase activity of up to 300% were
obtained in the presence of laminin but fibronectin and type
IV collagen had no effect (Figure 1). Bovine serum albumin
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Figure 1 Type IV collagenase activity for the parent and met B
cell lines. Laminin E (8upgml-1), fibronectin a (20pgml-1) and
type IV collagen Ol (20pgml-1) was added to the 24h serum-
free culture media. BSA * (10pgml-) was included as a
negative control in addition to the untreated E control flasks.
BSA, fibronectin and type IV collagen at lower concentrations
did not alter type IV collagenase activity'
Pre-treatment of flasks with laminin, fibronectin and type IV
collagen gave similar results to the addition of BM components
to the collection media.
(BSA) was included in all experiments (10pgml-1) as a
negative control.
Experiments using different concentrations of laminin
showed type IV collagenase activity to be dose-dependent,
the saturating concentration being in excess of 8pgml-1
(Figure 2). A concentration of 6.0pgml-1 laminin added to
the serum-free culture medium was used in the subsequent
series of experiments.
Basal levels and the effect of laminin on the secretion of
type IV collagenase for high and low metastatic cell lines
Table I shows the origin and metastatic profile of the cell
lines investigated and their basal level of type IV collagenase
activity. Thus, low/non-metastatic cell lines (parent and S9E)
produced intermediate levels of type IV collagenase. The
highly metastatic cell lines (met B, met F and S4A) however,
consistently expressed less type IV collagenase activity than
the parental cell line. In contrast, the low/non-metastatic cell
lines (met C and particularly met G) secreted more type IV
collagenase activity compared to the primary parent tumour.
The parental cell line, met C, met G and S9E (low/non-
metastatic) and met B, met F and S4A (highly metastatic)
were grown to subconfluency prior to adding laminin
(6Mgml-1) or BSA (6ygml-1) to serum-free culture col-
lection media (see Figure 3).
The presence of laminin increased type IV collagenase
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Figure 2 The effect of different concentrations of laminin
(ugml-l in serum-free collection media) for the met B cell line.
Laminin or BSA was added to the 24h collection media. A cell
count was performed after this period and the results are
expressed as the percentage increase for laminin above the BSA
control (cpm 10-6 cells laminin)/(cpm 10-6 cells BSA) x 100.
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activity by up to 100% for the parent cell line and the in
vitro clone, S4A. Met B and met F (in vivo sublines) showed
increased expression of BM collagenase by 220% and 190%
respectively. Met C and met G (in vivo sublines) and S9E (in
vitro clone) showed no increase in type IV collagenase
expression following the addition of laminin (Figure 3).
The effect of laminin, fibronectin and type IV collagen on
PA activity for the hamster tumour cell lines
The basal level of PA activity for the cell lines studied,
together with their origin and metastatic profile are given in
Table I. All cell lines secreted similar levels of PA activity
demonstrating no correlation between the secretion of PA
and their metastatic propensity.
Laminin, fibronectin and type IV collagen, used at the
concentrations described for type IV collagenase, were either
added to the culture media or used to coat 60mm plastic
petri dishes. Neither laminin, fibronectin nor type IV
collagen-coated petri dishes, at any of the concentrations,
affected the PA activity of the parent or the met B cell line
(results not shown). Similarly, laminin, fibronectin or type
IV collagen added to the culture media either for the 24h
prior to the 5h serum-free collection period, during the
serum-free collection period or present during the overnight
culture period and during the serum-free collection period,
did not affect the level of PA activity for any of the cell lines
(see Table II). Similar results were obtained for the parent,
S4A and met G cell lines (results not shown)
Type IV collagenase and PA secretion from cocultures of
tumour cells and lung fibroblasts
Hamster fibroblasts were grown to confluency in 175 cm2
tissue culture flasks. The cell monlayer was washed three
times in Hanks BSS and 5 x 106 parent or met B tumour
cells were added per flask in serum-free medium (25ml).
Control flasks included lung fibroblasts alone and tumour
cells alone (in 25ml serum-free medium).
Serum-free collection medium was harvested after 5h and
24h incubation at 37°C and assayed for type IV collagenase
or PA activity. The results, (see Table III) showed lung
fibroblasts to secrete intermediate levels of type IV col-
lagenase (70-120cpm 10-6 cells) whilst parent and met B
cells secreted type IV collagenase to the levels demonstrated
in previous experiments (approximately 90-100 and 50-
70cpmlO-6 cells respectively). Activity for lung fibroblasts
overlaid with tumour cells showed a significant (P<0.001)
decrease in type IV collagenase activity compared with the
Cell
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Figure 3 The effect of laminin on secreted type IV collagenase
activity for the parent tumour and its in vivo sublines and in
vitro clones. Laminin (6jugml 1) and BSA (6ggml - 1) were
added to the serum-free 24h collection media. After this period
the media was harvested for type IV collagenase assay and a cell
count performed. The enzyme activity was calculated as
cpm 10-6 cells as percentages of the BSA control which was
adjusted to 100 cpm10-6 cells.
Table II The effect of laminin, fibronectin and type IV collagen on
plasminogen activator activity for met B tumour cells.
Component
added
Laminin
(6pgml 1)
Fibronectin
(20pgml -1)
Type IV collagen
(20 ugml 1)
24h culture
period (CMEM
10% FCS)
+
+
+
5h serum-free
collection
period
+
+
+
+
% PA activity
10-5 cells
21.19
21.75a
19.22a
18.99a
21.19
23.37a
20.11a
19.46a
26.82
25.44a
25.37a
24.loa
3 x 104 cells were subcultured in 60mm petri dishes in 5ml
CMEM+10% FCS and incubated for 24h at 37°C (5% CO /95%
air). The media was discarded and the cells were washed twice in
Hanks BSS and incubated for a further 5 h in CMEM (serum-free).
The supernatant was harvested and assayed for PA activity and a
cell count was performed on the remaining monolayer. The results
were shown to be reproducible in repeat experiments. Pre-coating
60mm petri dishes prior to addition of tumour cells had no effect on
PA activity (results not shown). Similar results were obtained for the
paIrent. milet G aind S9E cell lines. aNo significant difference
(Student's t test) between test and control values.
predicted value (sum) after a 24h collection period. No
difference was observed after a 5 h collection period. Serum-
free culture supernatants were also assayed for PA activity
(see Table IV). After 24h coculture (parent or met B cells
plus lung fibroblast) the PA activity was similar to the sum
of PA activity for lung fibroblasts and tumour cells grown
independently for 24h. At 5 h coculture, however, PA
activity for met B tumours and lung fibroblasts was signifi-
cantly higher than the predicted sum. Similar results were
obtained for the parent cell line although the increase was
not statistically significant (see Table IV).
Discussion
Previous studies have reported a correlation between the
change from the normal to the malignant cell phenotype and
the ability to secrete the basement membrane degrading
metalloproteinase, type IV collagenase (Salo et al., 1982). A
similar correlation has been reported between non-metastatic
and metastatic cell types (Liotta et al., 1980; Nakajima et al.,
1987) and more recently the increased expression of type IV
collagenase activity has been correlated with the increased
metastatic capacity of murine tumour cell hybrids
(Turpeeniemi-Hujanen et al., 1985).
In a previous report from this laboratory, we were able to
confirm that a HSV-2-induced hamster fibrosarcoma tumour
cell line and sublines derived from its in vivo metastases, or
its in vitro derived clones were able to express type IV
collagenase activity (Teale et al., 1987). No correlation
between metastatic propensity and the level of type IV
collagenase activity, however, was noted. This may be at-
tributable to the immunological status of non-metastatic
lines, since Turpeeniemi-Hujanen et al. (1985) found that
non-metastatic murine tumour cell lines which expressed type
IV collagenase activity were able to metastasize in nude
mice.
In the present communication we have demonstrated that
the expression of type IV collagenase activity by metastatic
cell lines, but not non/weakly metastatic cell lines, is
enhanced by laminin. Fibronectin and type IV collagen
having no influence on the secretion of this enzyme.
Type IV collagen is the major component of basement
membrane and forms a structural network upon which the
non-collagenous components, such as laminin and
.
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Table III Type IV collagenase activity for cocultures of lung fibroblasts with parent or
met B tumour cells.
Type IV collagenase activity (cpm 10-6 cells)
Sh collection 24h collection
Cell Exp. lung+ lung+
line no. lung tumour sum tumour lung tumour sum tumour
Met B 1. 22 6 28 30 117 55.2 172.2 28
2. NT 97 69.5 166.5 44.2a
3. NT 86 48.7 134.7 32.8a
Parent 1. 18 12 30 28 87 92 179 48.3a
2. NT 74 89 163 43.2a
Type IV collagenase activity was assessed 5h and 24h after the overlay of lung
fibroblasts with 5 x 106 parent or met B tumour cells/flask. Controls included lung
fibroblasts and 5 x 106 tumour cells added to empty flasks. A cell count was performed
after the collection period to enable type IV collagenase activity to be expressed with
regard to cell numbers. No difference was noted between the total cell count for lung
cells plus tumour cells cocultured and the sum of lung cells and tumour cells cultured
separately. Significance levels of type IV collagenase between coculture values (lung
fibroblasts with tumour cells) and the predicted sum (lung fibroblasts+tumour cells) was
assessed by Student's t test; ap<0.001; NT=Not tested.
Table IV Plasminogen activator activity for cocultures of lung fibroblasts with
parent or met B tumour cells.
% PA activity J0-s cells
Sh collection 24h collection
Cell lung+ lung+
line lung tumour sum tumour lung tumour sum tumour
Parent 1.9 0.34 2.24 5.4NS 58.7 8.4 67.1 67.9NS
1.5 5.2 6.7 11.1 NS 15.5 30.7 46.2 33.0NS
Met B 1.2 0.17 1.37 8.3b 5.3 10.5 15.87 1l.9NS
9.1 3.0 12.1 21.8NS 14 36.5 50.5 54.7NS
2.2 26.8 29.0 54.6a 19.2 81.1 100.3 78.7NS
Plasminogen activator activity was assessed 5h and 24h after the overlay of lung
fibroblasts with 5 x 106 parent or met B tumour cells/flask. Controls included lung
fibroblasts and 5 x 106 tumour cells added to empty flasks. A cell count was
performed after the collection period to enable plasminogen activator activity to be
expressed with regard to cell numbers. No difference was noted between the total cell
count for lung cells plus tumour cells cocultured and the sum of lung cells and
tumour cells cultured separately. Significance levels of plasminogen activator activity
between coculture values (lung fibroblasts with tumour cells) and the predicted sum
(lung fibroblasts+tumour cells) was assessed by Student's t test; ap<0.05; bp<0.01;
NS=Not significant.
fibronectin, are assembled (Timpl et al., 1979,1981; Carlin et
al., 1981; Kanwar & Farquar, 1979). Laminin serves as an
attachment protein for endothelial and epithelial cells (Timpl
et al., 1979; Lesot et al., 1983; Kefalides et al., 1979) and it
has been shown that metastatic tumour cells in vitro bind to
the basement membrane via laminin prior to degradation of
type IV collagen (Terranova et al., 1982). In a recent
communication (Turpeeniemi-Hujanen et al., 1986) the
binding of laminin to human melanoma cells, the HT
fibrosarcoma and the B16 melanoma, increased type IV
collagenase activity by up to 300% in these cell lines.
In addition to this, a monoclonal antibody against the
human laminin receptor blocked the effect of laminin on
type IV collagenase activity. This study would, therefore,
suggest that the binding of laminin to a tumour cell, which
mimics the binding to a basement membrane, induces the
secretion of type IV collagenase and the dissolution of the
basement membrane (Turpeeniemi-Hujanen et al., 1986).
We have found that laminin added to the serum-free
culture media can augment the expression of type IV col-
lagenase in metastatic but not non-metastatic cell lines. Non
or weakly metastatic cell lines, however, appear to express a
basal level of type IV collagenase which is greater than that
of their metastatic sister cell lines. This would suggest that
specific control of release of type IV collagenase at the time
of tumour cell attachment to the basement membrane, via
interaction with laminin, may be more important than the
continued background secretion of type IV collagenase.
These results are in keeping with those of Terranova et al.,
1982, who demonstrated enhanced metastatic capacity of
tumour cells selected by attachment to laminin. Fibronectin
did not select for the metastatic phenotype.
In addition to studying the effect of BM components on
type IV collagenase we also report on their effect on
plasminogen activator (PA) secretion. PA induces the
activation of plasminogen giving rise to plasmin which has
been associated with the ability of tumour cells to
metastasize (Carlson et al., 1984; Wang et al., 1980)
possibility by its ability to degrade laminin (Liotta et al.,
1981). We have previously shown that the hamster tumour
cell lines used here are able to recrete PA but no correlation
between the level of PA secretion and the metastatic profile
was found (Khidair et al., 1986). We are now able to report
that the addition of laminin, fibronectin or type IV collagen
to the tumour cell lines failed to alter the expression of
plasminogen activator activity. The initial inter-reaction
between tumour cells and lung fibroblasts during in vitro
coculture, however, did augment PA activity, but appeared
to inhibit type IV collagenase expression. It is possible that
normal cells are able to suppress type IV collagenase
activity, and this mechanism may serve to down-regulate
type IV collagenase activity at an appropriate stage of the
metastatic processs. On the other hand initial interaction of
tumour cells with normal lung fibroblasts (in vitro) caused an
initial increase in PA activity (it is, however, undetermined
whether tumour cells or fibroblasts are responsible for this480 D.M. TEALE et al.
release) and the interaction of metastasizing tumour cells
with lung fibroblasts may initiate PA and induce the internal
degradation of the BM via laminin degradation. It is
generally believed that the physiological turnover of base-
ment membranes is controlled by a cascade of proteases
(Salo et al., 1982; Turpeeniemi-Hujanen et al., 1986), type IV
collagenase and PA being two examples. The control of
these proteases is not fully understood but it would appear
from the present study, and the literature, that the binding
of laminin by tumour cells may be one controlling factor for
type IV collagenase expression. PA would appear not to be
enhanced at the basement membrane but may serve as a
second thrust of enzyme degradation, possibly from the
'internal' side of the basement membrane barrier upon
interaction with cell types confined by the basement
membrane.
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